Everest Organics informs about appointment of additional director

13 Jan 2025 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Everest Organics has informed that the Board of Directors of the Company at their meeting held today January 13, 2025 approved the appointment of Kirankumar Rampally (DIN: 07621817) as Additional Director of the Company in Non-Executive Independent category with effect from January 13, 2025, for a period of 5 consecutive years, subject to approval of members within 3 Months from January 13, 2025. Kirankumar Rampally (DIN: 07621817), has not been debarred from holding the office of director by virtue of any SEBI order or any other such authority as required under BSE Circular no. LIST/COMP/14/2018- 19 and NSE Circular no. NSE/CML/2018/24, dated June 20, 2018. Disclosure as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015 is provided at Annexure I.

The above information is a part of company’s filings submitted to BSE.

Everest Organics Share Price

308.75 0.00 (0.00%)
11-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1707.80
Dr. Reddys Lab 1141.75
Cipla 1480.00
Lupin 1995.15
Zydus Lifesciences 884.90
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...